SFC

Sommaire


CARDIOLOGIE PÉDIATRIQUE

CARDIO-ONCOLOGIE

CORONAIRES ET INTERVENTIONNEL

  • 📌 ​À LA UNE : Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial | Lire l'article JAMA
  • Drug-Coated Balloons for In-Stent Restenosis - Finally Leaving Nothing Behind for US Patients | Lire l'article JAMA
  • National Trends and Outcomes of Acute Myocardial Infarction After Transcatheter Aortic Valve Replacement | Lire l'article JACC

HTA

IMAGERIE CARDIOVASCULAIRE

  • 📌 ​À LA UNE : Associations of Alcohol Consumption With Left Atrial Morphology and Function in a Population at High Cardiovascular Risk | Lire l'article JAHA
  • Left Ventricular Noncompaction in Childhood: Echocardiographic Follow-Up and Prevalence in First-Degree Relatives | Lire l'article JACC

INSUFFISANCE CARDIAQUE ET CARDIOMYOPATHIES

RISQUE CARDIOVASCULAIRE

RYTHMOLOGIE

  • 📌 ​À LA UNE : Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials | Lire l'article Circulation
  • Contemporary catheter ablation of complex atrial tachycardias after prior atrial fibrillation ablation: pulsed field versus radiofrequency current energy ablation guided by high-density mapping | Lire l'article EP Europace
  • Diagnosis and Management of Paroxysmal Supraventricular Tachycardia | Lire l'article JAMA
  • Focal point-by-point biphasic monopolar pulsed field ablation for posterior wall isolation | Lire l'article EP Europace
  • Left Atrial Cardiomyopathy: A Puzzling Disease Process Short of an Easy Answer | Lire l'article JAHA
  • Pulsed field ablation technology for pulmonary vein and left atrial posterior wall isolation in patients with persistent atrial fibrillation | Lire l'article Journal of Cardiovascular Electrophysiology
  • Subclinical Atrial Fibrillation and Anticoagulation: Weighing the Absolute Risks and Benefits | Lire l'article Circulation
  • The Natural History of Atrial Functional Mitral Regurgitation | Lire l'article JACC

USIC

  • 📌 ​À LA UNE : Enhanced Decongestive Therapy in Patients With Acute Heart Failure: JACC Review Topic of the Week | Lire l'article JACC
  • Myocardial Infarction After TAVR: Much Ado About Nothing? | Lire l'article JACC

VALVULOPATHIES

  • 📌 ​À LA UNE : Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study | Lire l'article The Lancet
  • The future of valvular heart disease assessment and therapy | Lire l'article The Lancet
  • Conservative Versus Surgical Therapy in Patients With Infective Endocarditis and Surgical Indication—Meta‐Analysis of Reconstructed Time‐to‐Event Data | Lire l'article JAHA
  • Impact of Prosthesis‐Patient Mismatch After Surgical Aortic Valve Replacement: Systematic Review and Meta‐Analysis of Reconstructed Time‐to‐Event Data of 122 989 Patients With 592 952 Patient‐Years | Lire l'article JAHA
  • Prevalence and Prognostic Implications of Pulmonary Hypertension in Patients With Severe Aortic Regurgitation | Lire l'article JACC

DEEP LEARNING ET INTELLIGENCE ARTIFICIELLE

COVID

  • 📌 ​À LA UNE : Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19 | Lire l'article JACC
  • COVID-19 Associated With Higher Risk of Autoimmune Diseases | Lire l'article JAMA
  • Lower vs Higher Oxygenation Target and Days Alive Without Life Support in COVID-19: The HOT-COVID Randomized Clinical Trial | Lire l'article JAMA
  • Myocardial Blood Flow Quantified Using Stress Cardiac Magnetic Resonance After Mild COVID-19 Infection | Lire l'article JACC
  • Therapeutic-Dose Anticoagulation in Hospitalized Patients With COVID-19: Are We Getting Closer to the Truth? | Lire l'article JACC

LA FRANCE À L’HONNEUR

  • 📌 ​À LA UNE : Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl | Lire l'article JACC

Nos suggestions d’actualités

Les actualités Cardio Online

Muvalaplin : nouvel inhibiteur de la lp(a) par voie orale

21 novembre 2024

Pas de supériorité d’un système d’aide à la décision pour optimiser les thérapies hypolipémiantes dans le post SCA

21 novembre 2024

Efficacité et sécurité d’emploi de l’obicetrapib, un nouvel inhibiteur de la CETP

21 novembre 2024

Zerlasiran, encore un nouvel antiLp(a) en développement

21 novembre 2024

L’edoxaban pour la prévention de thrombose valvulaire

20 novembre 2024

21/11/2024
Actualités Communautés
Newsletter

Newsletter de la SFHTA - Novembre 2024

21/11/2024
Actualités Congrès
Congrès

Impact environnemental de la cardiologie : Participez à notre enquête nationale !

20/11/2024
Actualités Communautés
Communautés

Congrès FCPC 2027 et 2028 : Appel à candidatures